fbpx

Year

2011
Download press release here: Acacia_Pharma_starts_Phase_II_clinical_trail_f.PDF
DBV demonstrates ability of VIASKIN® to administer allergen via intact skin by targeting dendrictic cells for safe treatment of allergic disease. News_J_Immunol.pdf
The U.S. Food and Drug Administration has granted 510(k) clearance for Asante Solutions' Pearl Insulin Pump. ASANTE_press_release_051711.pdf
Syntaxin enters manufacturing agreement with SynCo Bio Partners B.V. Progresses Acromegaly programme towards clinic. SynCo_Bio_Release_9_5_2011_(2).pdf
The Lundbeck Foundation, KIRKBI and the members of Falck's Executive Management Board become principal shareholders of Falck and Nordic Capital Fund V (Nordic Capital") sells all its shares in Falck."
Funds to be used to complete two Phase II programmes
In 2010 the Lundbeck Foundation obtained a profit of DKK 2.7 billion (? 362 million) which is the second best result since its establishment in 1954.
Three Hungarian neuroscientists awarded the ? 1 million BRAIN PRIZE 2011 for their brilliant analysis of brain circuits involved in memory
1 2 3

News

Experienced neuroscientist at the helm of The Brain Prize
30. June 2020
Eight promising young researchers receive Lundbeck Foundation Fellowships
16. June 2020
Denmark Gets Its First Master’s Degree Programme in Neuroscience
4. June 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge